Moderna's COVID-19 vaccine 94.5 percent effective in Phase 3 study

Barron News Shield

Nov 16, 2020

(The Center Square) -- Biotech company Moderna announced Monday that its new COVID-19 vaccine has proven to be 94.5 % effective. |!| Barron